Scynexis (SCYX) Cash from Operations (2013 - 2026)
Scynexis' (SCYX) quarterly Cash from Operations came in at 8101000.0 in Q1 2026, down 8.52% YoY from 8855464.2 in Q1 2025, and down 144.02% on a QoQ basis from 18401000.0 in Q4 2025.
Scynexis (SCYX) Cash from Operations (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Cash from Operations data on file, last reported at 8101000.0 in Q1 2026.
- Quarterly Cash from Operations fell 8.52% year-over-year to 8101000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5919000.0 (up 78.45% YoY) and the FY2025 annual result came in at 5283000.0, up 78.0% from the prior year.
- Cash from Operations declined to 8101000.0 in Q1 2026, from 18401000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 74398000.0 in Q2 2023 to a low of 22806000.0 in Q4 2022.
- A 5-year average of 3359823.53 and a median of 8101000.0 in 2026 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations slumped 2006.46% — and 2023, when it surged 500.4%.
- Tracing SCYX's Cash from Operations over 5 years: stood at 22806000.0 in 2022, then jumped by 66.08% to 7735000.0 in 2023, then decreased by 28.08% to 9907000.0 in 2024, then jumped by 285.74% to 18401000.0 in 2025, then sank by 144.02% to 8101000.0 in 2026.
- The last three Cash from Operations figures came in at 8101000.0 (Q1 2026), 18401000.0 (Q4 2025), and 8724000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - | -14.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.89 Mn |
| Jun 30, 2026 | -14.89 Mn |
| Mar 31, 2026 | -8.10 Mn |
| Mar 31, 2026 | -8.10 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Jun 30, 2025 | -7.50 Mn |
| Jun 30, 2025 | -7.50 Mn |
| Mar 31, 2025 | -7.47 Mn |
| Mar 31, 2025 | -7.47 Mn |
| Dec 31, 2024 | -9.91 Mn |
| Dec 31, 2024 | -9.91 Mn |
| Sep 30, 2024 | 765,000.00 |
| Sep 30, 2024 | 765,000.00 |
| Jun 30, 2024 | -10.86 Mn |
| Jun 30, 2024 | -10.86 Mn |
| Mar 31, 2024 | -4.01 Mn |
| Mar 31, 2024 | -4.01 Mn |